Stamceller
Cell types, regenerative therapies, regulatory status, and disease-by-disease evidence for stem cell medicine, from FDA-approved bone marrow transplants to unproven clinic infusions.
Athletes and Stamceller: Documented vs Anecdote
Five famous athlete stem cell stories get repeated as proof stamceller work. The primär sources show a range from solidly confirmed to media speculation, and regulators say none of it counts as evidence.
EMA Regulation of Stem Cell Therapies
The EU treats stem cell produkter as Advanced Therapy Medicinal Produkter; only Holoclar remains fully approved after Alofisel's 2024 withdrawal, and roughly a fifth of all approved ATMPs have left the market.
Embryonic Stamceller (ESC)
Pluripotent cells taken from early-stage embryos remain the most flexible stem cell type in research but the most regulated in practice, with only a handful of human trials and no full approval anywhere.
Exosomes vs Stamceller: What's the Difference
Exosomes are cell-free nanoparticles, not living stamceller, but the FDA says clinics market them the same way, and zero exosome produkter carry approval anywhere.
Exosomes: Therapy, Longevity, and Regelverk Status
Cell-to-cell messengers that carry proteins and RNA between cells. Young and stem-cell-derived exosomes rejuvenate old tissue in mice, but zero FDA-approved exosome produkter exist and adverse events are documented.
FDA Regulation of Stem Cell Therapies
The FDA has fully licensed roughly 43 cell and gene therapy produkter, almost none of them stem cell produkter beyond cord blood, while running an escalating enforcement campaign against unapproved stem cell clinics.
Hematopoietic Stamceller (HSC)
Bone-marrow-derived blood-forming stamceller behind the oldest and most FDA-approved stem cell therapy in medicine, the transplant used against leukemia and other blood disorders.
Induced Pluripotent Stamceller (iPSC)
Lab-reprogrammed adult cells that behave like embryonic stamceller without requiring an embryo, now entering human trials for Parkinson's disease and diabetes, though no iPSC therapy is yet approved.
Mesenchymal Stamceller (MSC)
MSCs are multipotent adult stamceller that work mainly through secreted signaling molecules, not by becoming new tissue, and they dominate the commercial stem cell market despite almost no full drug approvals.
Partial Epigenetic Reprogramming
Altos Labs and Life Biosciences are testing Yamanaka-factor-based partial reprogramming to reverse cellular aging markers without creating pluripotency, a mechanism distinct from stem cell transplantation despite using the same discovery.
Stem Cell Clinic Pricing by Country: What It Actually Costs
Offshore stem cell clinics charge $2,000 to $50,000+ per treatment, but almost every published number comes from the clinics or the brokers selling them.
Stem Cell Bevisning Tiers: Our Metodik
A five-level framework, from tier 1 regulatory-grade human evidence to tier 5 unsupported hypothesis, that we apply consistently across every stem cell page in this encyclopedia.
Stem Cell Säkerhet and Red Flags
Pew Charitable Trusts documented roughly 360 adverse events linked to unapproved US stem cell interventions between 2004 and 2020, and the ISSCR's patient handbook lists specific marketing red flags to check before any procedure.
Stem Cell Types: A Comparison Overview
Five stem cell types used in medicine differ in origin, potency, and regulatory status; only cord-blood-derived hematopoietic cells and two European ATMPs carry full approval.
Stamceller for Alzheimer's Disease
Longeveron's CLEAR MIND Phase 2a trial found laromestrocel slowed brain volume decline by up to 61.9% in mild Alzheimer's disease, but the trial was safety-focused and too small to prove a cognitive benefit.
Stamceller for Diabetes
Vertex's stem-cell-derived islet therapy zimislecel achieved insulin independence in 83% of evaluable type 1 diabetes patients at one year, the strongest human efficacy signal in this entire encyclopedia section.
Stamceller for Frailty
Longeveron's laromestrocel is the most rigorously tested MSC therapy for aging-related frailty, showing a 63.4-meter six-minute-walk improvement at nine months, but it remains unapproved.
Stamceller for Hair Loss
A 2024 systematisk översikt of 12 RCTs and 514 patients found stem cell and stem-cell-secretome injections modestly boost hair density, but no randomized trial of exosomes for pattern hair loss existed as of that review, and clinics still sell exosome hair packages off that evidence gap.
Stamceller for Knee Osteoarthritis
The largest meta-analyses show MSC injections modestly outperform placebo for knee osteoarthritis pain and function, but a 2025 study estimates that 50-66% of the apparent benefit comes from placebo and contextual effects, not the cells themselves.
Stamceller for Stroke
The MASTERS trial program tested an allogeneic adult stem cell product in over 300 acute ischemic stroke patients and found no significant benefit on the primär endpoint, making stroke the weakest evidence case in this section.
Umbilical Cord Stamceller: Legitimate Use vs Clinic Produkter
Cord-blood stamceller are the only FDA-approved stem cell product on the US market, but that approval covers blood-disorder transplants only; the umbilical cord produkter sold for pain, aging, and joints caused a 12-to-20-patient bacterial infection outbreak in 2018 and continue to draw FDA warning letters, most recently in februari 2026.